Español
Español English Português 日本
LKC Technologies Vision Defined TM

Webinar Recording Below

Aired: June 16th, 2021 7:00 PM EDT (New York)

Optimizing Patient Outcomes with the RETeval® Device

Dr. Michael Cymbor, O.D., F.A.A.O.

Presented By:
Dr. Michael Cymbor, OD, FAAO

Interested in putting the power of ERG into your hands?
Fill out the form to talk to us about the RETeval® Device!

About the Webinar

What is ERG?

ERG testing has been established as one of the earliest indicators of eye disease, showing functional stress due to glaucoma and diabetic retinopathy well before damage appears on structural imaging.

ERG Technology Is Advancing

And the technology for ERG testing has continued to progress. Today’s ERG testing with the handheld RETeval device is rapid, efficient, and easy to interpret. And working it into a busy practice has never been easier. The RETeval Device requires no corneal electrode. Instead, it uses patented electrode sensor strips. What’s more, dynamic pupillometry allows the RETeval device to work on dilated and undilated patients alike, with a color-coded reference set for straightforward report interpretation.

Optimizing Patient Outcomes

Join Dr. Cymbor as he discusses how he incorporates the RETeval device into his busy medical optometric practice and how it aids in optimizing patient outcomes. We will conclude with an open Q&A session.

Dr. Michael Cymbor, O.D., F.A.A.O.

About

Dr. Michael Cymbor, OD, FAAO

Michael Cymbor, OD, FAAO is an ocular disease lecturer, researcher and is published in numerous journals and publications. He is a managing partner of Nittany Eye Associates in State College, PA. He is also the medical director of the Glaucoma Institute of State College and a member of the Optometric Glaucoma Society and National Glaucoma Society.

Dr. Cymbor is an adjunct clinical professor at the Pennsylvania College of Optometry (SALUS). He is a fellow in the American Academy of Optometry and was named past “Young Optometrist of the Year” by the American Optometric Association. Michael received his optometric doctorate from the Pennsylvania College of Optometry (SALUS) and completed a residency at the Wilkes-Barre VA Medical Center.

Want to learn more?
Talk to us

cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2024 LKC Technologies, Inc.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity